

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic metaphase plate congression (GO:0007080) | 7.45932882 |
| 2 | metaphase plate congression (GO:0051310) | 7.29208845 |
| 3 | purine nucleobase biosynthetic process (GO:0009113) | 6.99423854 |
| 4 | * vitamin transmembrane transport (GO:0035461) | 6.69274789 |
| 5 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 6.36736603 |
| 6 | regulation of spindle organization (GO:0090224) | 5.94369816 |
| 7 | nucleobase biosynthetic process (GO:0046112) | 5.67168671 |
| 8 | modified amino acid transport (GO:0072337) | 5.62056979 |
| 9 | ribosome biogenesis (GO:0042254) | 5.48858229 |
| 10 | folic acid metabolic process (GO:0046655) | 5.47894083 |
| 11 | folic acid transport (GO:0015884) | 5.35647794 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 5.28675591 |
| 13 | rRNA modification (GO:0000154) | 5.19563953 |
| 14 | establishment of chromosome localization (GO:0051303) | 5.12728602 |
| 15 | lung-associated mesenchyme development (GO:0060484) | 5.11183091 |
| 16 | transcription from mitochondrial promoter (GO:0006390) | 4.97278799 |
| 17 | regulation of mitotic spindle organization (GO:0060236) | 4.88464543 |
| 18 | ribosome assembly (GO:0042255) | 4.85596146 |
| 19 | rRNA methylation (GO:0031167) | 4.84504462 |
| 20 | positive regulation of chromosome segregation (GO:0051984) | 4.72379758 |
| 21 | DNA replication checkpoint (GO:0000076) | 4.62910039 |
| 22 | regulation of exit from mitosis (GO:0007096) | 4.61172275 |
| 23 | urate metabolic process (GO:0046415) | 4.57588645 |
| 24 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 4.56289013 |
| 25 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.52413238 |
| 26 | behavioral response to nicotine (GO:0035095) | 4.52372360 |
| 27 | negative regulation of fibroblast apoptotic process (GO:2000270) | 4.46825352 |
| 28 | maturation of 5.8S rRNA (GO:0000460) | 4.43206095 |
| 29 | termination of RNA polymerase I transcription (GO:0006363) | 4.42991445 |
| 30 | termination of RNA polymerase III transcription (GO:0006386) | 4.42519368 |
| 31 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.42519368 |
| 32 | blastocyst development (GO:0001824) | 4.41283429 |
| 33 | L-fucose catabolic process (GO:0042355) | 4.39870516 |
| 34 | fucose catabolic process (GO:0019317) | 4.39870516 |
| 35 | L-fucose metabolic process (GO:0042354) | 4.39870516 |
| 36 | pantothenate metabolic process (GO:0015939) | 4.39003253 |
| 37 | triglyceride catabolic process (GO:0019433) | 4.37711589 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.35301044 |
| 39 | biotin metabolic process (GO:0006768) | 4.26961797 |
| 40 | transcription from RNA polymerase I promoter (GO:0006360) | 4.25228699 |
| 41 | centrosome localization (GO:0051642) | 4.24763016 |
| 42 | 7-methylguanosine mRNA capping (GO:0006370) | 4.17004157 |
| 43 | 7-methylguanosine RNA capping (GO:0009452) | 4.13272317 |
| 44 | RNA capping (GO:0036260) | 4.13272317 |
| 45 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 4.08614616 |
| 46 | drug catabolic process (GO:0042737) | 4.03273836 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 3.97735446 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 3.93485927 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.90128051 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.90128051 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.90128051 |
| 52 | meiosis I (GO:0007127) | 3.88459280 |
| 53 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.87290985 |
| 54 | ketone body metabolic process (GO:1902224) | 3.85472731 |
| 55 | acylglycerol catabolic process (GO:0046464) | 3.82049173 |
| 56 | neutral lipid catabolic process (GO:0046461) | 3.82049173 |
| 57 | S-adenosylmethionine metabolic process (GO:0046500) | 3.78640359 |
| 58 | protein localization to kinetochore (GO:0034501) | 3.78161102 |
| 59 | oocyte maturation (GO:0001556) | 3.74140598 |
| 60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.73823468 |
| 61 | inner cell mass cell proliferation (GO:0001833) | 3.73338281 |
| 62 | spindle checkpoint (GO:0031577) | 3.72897447 |
| 63 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.72794955 |
| 64 | * vitamin transport (GO:0051180) | 3.72252640 |
| 65 | GMP metabolic process (GO:0046037) | 3.71166523 |
| 66 | regulation of chromosome segregation (GO:0051983) | 3.70020200 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 3.68519107 |
| 68 | protein K6-linked ubiquitination (GO:0085020) | 3.67519629 |
| 69 | microtubule depolymerization (GO:0007019) | 3.67121139 |
| 70 | exogenous drug catabolic process (GO:0042738) | 3.66191763 |
| 71 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.64664877 |
| 72 | polyamine biosynthetic process (GO:0006596) | 3.61042317 |
| 73 | cofactor transport (GO:0051181) | 3.60127770 |
| 74 | positive regulation of vasculogenesis (GO:2001214) | 3.59480638 |
| 75 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.51362264 |
| 76 | endothelium development (GO:0003158) | 3.50970157 |
| 77 | protein localization to chromosome, centromeric region (GO:0071459) | 3.48469536 |
| 78 | ethanol oxidation (GO:0006069) | 3.47532836 |
| 79 | positive regulation of cell size (GO:0045793) | 3.46534766 |
| 80 | male meiosis I (GO:0007141) | 3.46028056 |
| 81 | kynurenine metabolic process (GO:0070189) | 3.44991550 |
| 82 | glycerol metabolic process (GO:0006071) | 3.40220221 |
| 83 | regulation of establishment of cell polarity (GO:2000114) | 3.36043696 |
| 84 | regulation of G0 to G1 transition (GO:0070316) | 3.36042136 |
| 85 | mitotic spindle checkpoint (GO:0071174) | 3.34212557 |
| 86 | fatty acid transmembrane transport (GO:1902001) | 3.33614382 |
| 87 | neurotransmitter catabolic process (GO:0042135) | 3.33082168 |
| 88 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.32670241 |
| 89 | triglyceride homeostasis (GO:0070328) | 3.30497174 |
| 90 | acylglycerol homeostasis (GO:0055090) | 3.30497174 |
| 91 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.30410051 |
| 92 | DNA-dependent DNA replication (GO:0006261) | 3.29945718 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 3.29841033 |
| 94 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.28777449 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 3.28233366 |
| 96 | negative regulation of macrophage differentiation (GO:0045650) | 3.26855691 |
| 97 | white fat cell differentiation (GO:0050872) | 3.26297402 |
| 98 | ventricular cardiac muscle cell development (GO:0055015) | 3.25071706 |
| 99 | phagocytosis, recognition (GO:0006910) | 3.24111223 |
| 100 | intestinal epithelial cell development (GO:0060576) | 3.23571866 |
| 101 | oxidative demethylation (GO:0070989) | 3.22472740 |
| 102 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.20731971 |
| 103 | DNA-templated transcription, elongation (GO:0006354) | 3.19179872 |
| 104 | glycine metabolic process (GO:0006544) | 3.18564705 |
| 105 | glycerolipid catabolic process (GO:0046503) | 3.16388333 |
| 106 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.15162267 |
| 107 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.13820461 |
| 108 | regulation of meiosis I (GO:0060631) | 3.13744155 |
| 109 | tryptophan metabolic process (GO:0006568) | 3.13409903 |
| 110 | diacylglycerol metabolic process (GO:0046339) | 3.11516491 |
| 111 | response to pheromone (GO:0019236) | 3.10954135 |
| 112 | ovulation from ovarian follicle (GO:0001542) | 3.10401404 |
| 113 | positive regulation of glycolytic process (GO:0045821) | 3.09534130 |
| 114 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.08382578 |
| 115 | mitotic cell cycle arrest (GO:0071850) | 3.07883748 |
| 116 | transcytosis (GO:0045056) | 3.07830971 |
| 117 | positive regulation of viral transcription (GO:0050434) | 3.07352976 |
| 118 | mitotic sister chromatid segregation (GO:0000070) | 3.07025625 |
| 119 | histone H2A monoubiquitination (GO:0035518) | 3.06763342 |
| 120 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.03681452 |
| 121 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.00049851 |
| 122 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.00049851 |
| 123 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.00049851 |
| 124 | brown fat cell differentiation (GO:0050873) | 2.99897242 |
| 125 | alditol metabolic process (GO:0019400) | 2.99221107 |
| 126 | adhesion of symbiont to host (GO:0044406) | 2.96096834 |
| 127 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.95030702 |
| 128 | synaptonemal complex assembly (GO:0007130) | 2.94019764 |
| 129 | negative regulation of response to food (GO:0032096) | 2.93409886 |
| 130 | negative regulation of appetite (GO:0032099) | 2.93409886 |
| 131 | response to dietary excess (GO:0002021) | 2.93035094 |
| 132 | histone H2A ubiquitination (GO:0033522) | 2.92631326 |
| 133 | negative regulation of chromosome segregation (GO:0051985) | 2.92208263 |
| 134 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.91790565 |
| 135 | cellular response to gamma radiation (GO:0071480) | 2.91298698 |
| 136 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.90047327 |
| 137 | rRNA processing (GO:0006364) | 2.89857315 |
| 138 | histone exchange (GO:0043486) | 2.89627370 |
| 139 | mitotic nuclear envelope disassembly (GO:0007077) | 2.89156962 |
| 140 | positive regulation of fatty acid oxidation (GO:0046321) | 2.88814048 |
| 141 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.88792251 |
| 142 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.88792251 |
| 143 | NADH dehydrogenase complex assembly (GO:0010257) | 2.88792251 |
| 144 | arginine metabolic process (GO:0006525) | 2.88729022 |
| 145 | transcription from RNA polymerase III promoter (GO:0006383) | 2.88444105 |
| 146 | oogenesis (GO:0048477) | 2.88118399 |
| 147 | microtubule polymerization or depolymerization (GO:0031109) | 2.87262423 |
| 148 | response to nitrosative stress (GO:0051409) | 2.86866581 |
| 149 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.85845678 |
| 150 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.85727779 |
| 151 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.85646067 |
| 152 | detection of light stimulus involved in visual perception (GO:0050908) | 2.81811143 |
| 153 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.81811143 |
| 154 | phospholipid homeostasis (GO:0055091) | 2.81457078 |
| 155 | primary alcohol metabolic process (GO:0034308) | 2.79101307 |
| 156 | positive regulation of glomerulus development (GO:0090193) | 2.77233655 |
| 157 | estrogen biosynthetic process (GO:0006703) | 2.75597608 |
| 158 | plasma lipoprotein particle clearance (GO:0034381) | 2.75475530 |
| 159 | cysteine metabolic process (GO:0006534) | 2.71039542 |
| 160 | alkaloid metabolic process (GO:0009820) | 2.70992423 |
| 161 | indole-containing compound metabolic process (GO:0042430) | 2.70901811 |
| 162 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.70228009 |
| 163 | sulfation (GO:0051923) | 2.69675255 |
| 164 | negative regulation of telomere maintenance (GO:0032205) | 2.69635409 |
| 165 | ethanol metabolic process (GO:0006067) | 2.69363950 |
| 166 | arginine catabolic process (GO:0006527) | 2.67487432 |
| 167 | regulation of hippo signaling (GO:0035330) | 2.66346800 |
| 168 | glyoxylate metabolic process (GO:0046487) | 2.65549992 |
| 169 | primary amino compound metabolic process (GO:1901160) | 2.64476063 |
| 170 | valine metabolic process (GO:0006573) | 2.63757356 |
| 171 | retinol metabolic process (GO:0042572) | 2.63753267 |
| 172 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.62912806 |
| 173 | drug metabolic process (GO:0017144) | 2.61678131 |
| 174 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.58601846 |
| 175 | L-phenylalanine catabolic process (GO:0006559) | 2.58601846 |
| 176 | regulation of lipoprotein metabolic process (GO:0050746) | 2.56044531 |
| 177 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.55088182 |
| 178 | regulation of hexokinase activity (GO:1903299) | 2.54826040 |
| 179 | regulation of glucokinase activity (GO:0033131) | 2.54826040 |
| 180 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.54231265 |
| 181 | lipid particle organization (GO:0034389) | 2.53428820 |
| 182 | regulation of triglyceride metabolic process (GO:0090207) | 2.52988019 |
| 183 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.50689277 |
| 184 | alanine transport (GO:0032328) | 2.50237419 |
| 185 | somite development (GO:0061053) | 2.50073170 |
| 186 | cellular biogenic amine catabolic process (GO:0042402) | 2.49588339 |
| 187 | amine catabolic process (GO:0009310) | 2.49588339 |
| 188 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.49556908 |
| 189 | bile acid metabolic process (GO:0008206) | 2.48921537 |
| 190 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.48779029 |
| 191 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.48720756 |
| 192 | cAMP catabolic process (GO:0006198) | 2.45748963 |
| 193 | positive regulation of fatty acid transport (GO:2000193) | 2.42491952 |
| 194 | aromatic amino acid family metabolic process (GO:0009072) | 2.40631210 |
| 195 | benzene-containing compound metabolic process (GO:0042537) | 2.40330814 |
| 196 | lipid storage (GO:0019915) | 2.38374036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.96681186 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.74721403 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.76239862 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.59374431 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.79439247 |
| 6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.53496028 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.41871385 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.39008539 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 3.35529463 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18127656 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.17134832 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.89177893 |
| 13 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.86774871 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.76053810 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.68125014 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.54292716 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.47207379 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.46793321 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37100724 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.36282540 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.34855338 |
| 22 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.31570654 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.31292794 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.29452466 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.28892515 |
| 26 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22226444 |
| 27 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.19922842 |
| 28 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.19380809 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.17542592 |
| 30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.14544836 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06024457 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.96192152 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.93145601 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90930822 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.89400565 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.87307377 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.87283291 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86347063 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84323284 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79770944 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78413813 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75812853 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75378919 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.74682074 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74489940 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.74350144 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71145713 |
| 48 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.68038838 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67926170 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67608983 |
| 51 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65294133 |
| 52 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.61892384 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61781467 |
| 54 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.61574558 |
| 55 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.60622487 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59138848 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58265620 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.58049857 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57348473 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.53891488 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52969719 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.48974323 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48967353 |
| 64 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.46173121 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45879019 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44929329 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.44594767 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43327392 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.43185560 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42398791 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41908233 |
| 72 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41908233 |
| 73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.40444675 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.40444675 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40311300 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39278213 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37556244 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.37339035 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37018142 |
| 80 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37018129 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35352405 |
| 82 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34549147 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34495607 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.33631895 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33127243 |
| 86 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32350485 |
| 87 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32350485 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.32198204 |
| 89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32132545 |
| 90 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31724615 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30612153 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29482613 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29365801 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29365801 |
| 95 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29209323 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28199705 |
| 97 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.27592660 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27485676 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 1.26416670 |
| 100 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.24720790 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24609426 |
| 102 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23891281 |
| 103 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22959560 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22294860 |
| 105 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21902675 |
| 106 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19781279 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19297369 |
| 108 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18837866 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18703318 |
| 110 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18469287 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18414968 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16127339 |
| 113 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15971276 |
| 114 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15352249 |
| 115 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15245797 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13991561 |
| 117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13612712 |
| 118 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13490662 |
| 119 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12528791 |
| 120 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.12517961 |
| 121 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12474443 |
| 122 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10293933 |
| 123 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09934231 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09428534 |
| 125 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.09371653 |
| 126 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08278852 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08254192 |
| 128 | ERA_21632823_ChIP-Seq_H3396_Human | 1.07104356 |
| 129 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05906170 |
| 130 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05525160 |
| 131 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04888965 |
| 132 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04080195 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03133328 |
| 134 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02998943 |
| 135 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02721480 |
| 136 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01833880 |
| 137 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01661858 |
| 138 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00486721 |
| 139 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99923768 |
| 140 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99815271 |
| 141 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99621285 |
| 142 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99586013 |
| 143 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97773908 |
| 144 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97299218 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96441217 |
| 146 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95832345 |
| 147 | TBL1_22424771_ChIP-Seq_293T_Human | 0.94991586 |
| 148 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.94900224 |
| 149 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94708627 |
| 150 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94466609 |
| 151 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94448594 |
| 152 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94239596 |
| 153 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93847129 |
| 154 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93767559 |
| 155 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93140664 |
| 156 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93006285 |
| 157 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90016104 |
| 158 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89355351 |
| 159 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.88809807 |
| 160 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88775926 |
| 161 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.88741475 |
| 162 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88127333 |
| 163 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87865454 |
| 164 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87741283 |
| 165 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.86396477 |
| 166 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.85970102 |
| 167 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.85802632 |
| 168 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.84362297 |
| 169 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.82981725 |
| 170 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.82310830 |
| 171 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.82302473 |
| 172 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.82134168 |
| 173 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81181604 |
| 174 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80610357 |
| 175 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.79001781 |
| 176 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.78806816 |
| 177 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.78051903 |
| 178 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77011219 |
| 179 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.76903730 |
| 180 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73956283 |
| 181 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.73877350 |
| 182 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.73234541 |
| 183 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.72572707 |
| 184 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.72296574 |
| 185 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.72246760 |
| 186 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.71952764 |
| 187 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.71598656 |
| 188 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.70860371 |
| 189 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.69760173 |
| 190 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.69414906 |
| 191 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69394685 |
| 192 | ATF3_27146783_Chip-Seq_COLON_Human | 0.69227617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.53708081 |
| 2 | MP0003718_maternal_effect | 5.48095993 |
| 3 | MP0005670_abnormal_white_adipose | 4.84469705 |
| 4 | MP0003195_calcinosis | 4.20544782 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.95302291 |
| 6 | MP0002876_abnormal_thyroid_physiology | 3.77944054 |
| 7 | MP0004130_abnormal_muscle_cell | 3.28268930 |
| 8 | MP0005377_hearing/vestibular/ear_phenot | 3.00083337 |
| 9 | MP0003878_abnormal_ear_physiology | 3.00083337 |
| 10 | MP0003077_abnormal_cell_cycle | 2.83306444 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.78042927 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.77396827 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.74388431 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.64954169 |
| 15 | MP0008057_abnormal_DNA_replication | 2.64782812 |
| 16 | MP0003011_delayed_dark_adaptation | 2.64156276 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.60855929 |
| 18 | MP0002971_abnormal_brown_adipose | 2.59905555 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.59207334 |
| 20 | MP0005451_abnormal_body_composition | 2.52308721 |
| 21 | MP0003123_paternal_imprinting | 2.49682064 |
| 22 | MP0003136_yellow_coat_color | 2.35881297 |
| 23 | MP0002009_preneoplasia | 2.34085990 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.33947975 |
| 25 | MP0001730_embryonic_growth_arrest | 2.33849180 |
| 26 | MP0002638_abnormal_pupillary_reflex | 2.28454271 |
| 27 | MP0005666_abnormal_adipose_tissue | 2.19472041 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 2.16232863 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 2.15519421 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 2.11213116 |
| 31 | MP0008260_abnormal_autophagy | 2.10398733 |
| 32 | MP0008058_abnormal_DNA_repair | 1.99300289 |
| 33 | MP0009115_abnormal_fat_cell | 1.92138967 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.91860047 |
| 35 | MP0009840_abnormal_foam_cell | 1.89344197 |
| 36 | MP0004147_increased_porphyrin_level | 1.87125020 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.84481489 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.82944719 |
| 39 | MP0003959_abnormal_lean_body | 1.81641976 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.79682235 |
| 41 | MP0001672_abnormal_embryogenesis/_devel | 1.77585551 |
| 42 | MP0005380_embryogenesis_phenotype | 1.77585551 |
| 43 | MP0003786_premature_aging | 1.74613496 |
| 44 | MP0004885_abnormal_endolymph | 1.74591659 |
| 45 | MP0005395_other_phenotype | 1.66855770 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.64309802 |
| 47 | MP0005408_hypopigmentation | 1.63923676 |
| 48 | MP0002102_abnormal_ear_morphology | 1.62347967 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.62305336 |
| 50 | MP0005448_abnormal_energy_balance | 1.61128705 |
| 51 | MP0010307_abnormal_tumor_latency | 1.59981969 |
| 52 | MP0005334_abnormal_fat_pad | 1.59277591 |
| 53 | MP0001661_extended_life_span | 1.56552662 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.56245360 |
| 55 | MP0003938_abnormal_ear_development | 1.55959977 |
| 56 | MP0008872_abnormal_physiological_respon | 1.54723113 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.54537112 |
| 58 | MP0005375_adipose_tissue_phenotype | 1.53431571 |
| 59 | MP0004043_abnormal_pH_regulation | 1.51421691 |
| 60 | MP0003868_abnormal_feces_composition | 1.49090952 |
| 61 | MP0005535_abnormal_body_temperature | 1.48514159 |
| 62 | MP0003984_embryonic_growth_retardation | 1.45720302 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.45545472 |
| 64 | MP0000350_abnormal_cell_proliferation | 1.45160381 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.44876518 |
| 66 | MP0006138_congestive_heart_failure | 1.44559006 |
| 67 | MP0005360_urolithiasis | 1.42466294 |
| 68 | MP0003879_abnormal_hair_cell | 1.40666727 |
| 69 | MP0003186_abnormal_redox_activity | 1.39663287 |
| 70 | MP0002088_abnormal_embryonic_growth/wei | 1.38710206 |
| 71 | MP0002938_white_spotting | 1.36732599 |
| 72 | MP0009697_abnormal_copulation | 1.36455352 |
| 73 | MP0004084_abnormal_cardiac_muscle | 1.36386698 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.34786097 |
| 75 | MP0003941_abnormal_skin_development | 1.33985782 |
| 76 | MP0002970_abnormal_white_adipose | 1.33331631 |
| 77 | MP0002210_abnormal_sex_determination | 1.32712679 |
| 78 | MP0002163_abnormal_gland_morphology | 1.31969196 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.30626218 |
| 80 | MP0001756_abnormal_urination | 1.28851273 |
| 81 | MP0008995_early_reproductive_senescence | 1.28121057 |
| 82 | MP0003252_abnormal_bile_duct | 1.27989060 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 1.27373692 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.25163859 |
| 85 | MP0002132_abnormal_respiratory_system | 1.24827619 |
| 86 | MP0004215_abnormal_myocardial_fiber | 1.24798209 |
| 87 | MP0003937_abnormal_limbs/digits/tail_de | 1.24718708 |
| 88 | MP0003828_pulmonary_edema | 1.23767292 |
| 89 | MP0005332_abnormal_amino_acid | 1.23599685 |
| 90 | MP0004484_altered_response_of | 1.23538799 |
| 91 | MP0001697_abnormal_embryo_size | 1.22664926 |
| 92 | MP0005365_abnormal_bile_salt | 1.21348726 |
| 93 | MP0001485_abnormal_pinna_reflex | 1.20183437 |
| 94 | MP0001968_abnormal_touch/_nociception | 1.18351860 |
| 95 | MP0001542_abnormal_bone_strength | 1.18198507 |
| 96 | MP0009745_abnormal_behavioral_response | 1.17410873 |
| 97 | MP0001929_abnormal_gametogenesis | 1.16828855 |
| 98 | MP0009046_muscle_twitch | 1.16742706 |
| 99 | MP0001986_abnormal_taste_sensitivity | 1.16688434 |
| 100 | MP0005253_abnormal_eye_physiology | 1.15599409 |
| 101 | MP0005647_abnormal_sex_gland | 1.15222216 |
| 102 | MP0000653_abnormal_sex_gland | 1.14698141 |
| 103 | MP0000230_abnormal_systemic_arterial | 1.13794022 |
| 104 | MP0002127_abnormal_cardiovascular_syste | 1.13681802 |
| 105 | MP0003699_abnormal_female_reproductive | 1.13181043 |
| 106 | MP0001145_abnormal_male_reproductive | 1.12702081 |
| 107 | MP0009672_abnormal_birth_weight | 1.12383600 |
| 108 | MP0003315_abnormal_perineum_morphology | 1.10472429 |
| 109 | MP0003283_abnormal_digestive_organ | 1.07626818 |
| 110 | MP0002086_abnormal_extraembryonic_tissu | 1.05758861 |
| 111 | MP0006292_abnormal_olfactory_placode | 1.05732339 |
| 112 | MP0002080_prenatal_lethality | 1.05365742 |
| 113 | MP0001188_hyperpigmentation | 1.03748793 |
| 114 | MP0001545_abnormal_hematopoietic_system | 1.03104475 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 1.03104475 |
| 116 | MP0002736_abnormal_nociception_after | 1.02690787 |
| 117 | MP0005386_behavior/neurological_phenoty | 1.01928759 |
| 118 | MP0004924_abnormal_behavior | 1.01928759 |
| 119 | MP0000427_abnormal_hair_cycle | 1.01702349 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.99395222 |
| 121 | MP0002085_abnormal_embryonic_tissue | 0.99260754 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.97955898 |
| 123 | MP0004142_abnormal_muscle_tone | 0.97229032 |
| 124 | MP0001119_abnormal_female_reproductive | 0.96827944 |
| 125 | MP0005452_abnormal_adipose_tissue | 0.96801441 |
| 126 | MP0003646_muscle_fatigue | 0.96043847 |
| 127 | MP0004133_heterotaxia | 0.94382679 |
| 128 | MP0003724_increased_susceptibility_to | 0.94143554 |
| 129 | MP0002272_abnormal_nervous_system | 0.92875291 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.91715561 |
| 131 | MP0005595_abnormal_vascular_smooth | 0.91615997 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.91523794 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.91152818 |
| 134 | MP0000372_irregular_coat_pigmentation | 0.90692296 |
| 135 | MP0002084_abnormal_developmental_patter | 0.90658136 |
| 136 | MP0003953_abnormal_hormone_level | 0.88171207 |
| 137 | MP0002733_abnormal_thermal_nociception | 0.87619358 |
| 138 | MP0002837_dystrophic_cardiac_calcinosis | 0.87514038 |
| 139 | MP0005503_abnormal_tendon_morphology | 0.87064045 |
| 140 | MP0005310_abnormal_salivary_gland | 0.85420358 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.84994428 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.82119580 |
| 143 | MP0004883_abnormal_blood_vessel | 0.81842829 |
| 144 | MP0005646_abnormal_pituitary_gland | 0.81753513 |
| 145 | MP0000750_abnormal_muscle_regeneration | 0.81328483 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.80230710 |
| 147 | MP0002160_abnormal_reproductive_system | 0.78171782 |
| 148 | MP0005195_abnormal_posterior_eye | 0.77831625 |
| 149 | MP0004742_abnormal_vestibular_system | 0.77621144 |
| 150 | MP0001486_abnormal_startle_reflex | 0.76617785 |
| 151 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76537624 |
| 152 | MP0000003_abnormal_adipose_tissue | 0.76114155 |
| 153 | MP0001984_abnormal_olfaction | 0.74248665 |
| 154 | MP0005174_abnormal_tail_pigmentation | 0.74243389 |
| 155 | MP0000631_abnormal_neuroendocrine_gland | 0.73951913 |
| 156 | MP0003137_abnormal_impulse_conducting | 0.73730799 |
| 157 | MP0004264_abnormal_extraembryonic_tissu | 0.73009440 |
| 158 | MP0004185_abnormal_adipocyte_glucose | 0.72246428 |
| 159 | MP0004145_abnormal_muscle_electrophysio | 0.70568392 |
| 160 | MP0001944_abnormal_pancreas_morphology | 0.70486999 |
| 161 | MP0009780_abnormal_chondrocyte_physiolo | 0.69824361 |
| 162 | MP0002139_abnormal_hepatobiliary_system | 0.69392818 |
| 163 | MP0001970_abnormal_pain_threshold | 0.68268058 |
| 164 | MP0002161_abnormal_fertility/fecundity | 0.68003172 |
| 165 | MP0001293_anophthalmia | 0.67577384 |
| 166 | MP0005187_abnormal_penis_morphology | 0.67064096 |
| 167 | MP0002092_abnormal_eye_morphology | 0.66826398 |
| 168 | MP0000462_abnormal_digestive_system | 0.66072084 |
| 169 | MP0000432_abnormal_head_morphology | 0.64544267 |
| 170 | MP0005330_cardiomyopathy | 0.64481957 |
| 171 | MP0004808_abnormal_hematopoietic_stem | 0.64235546 |
| 172 | MP0003656_abnormal_erythrocyte_physiolo | 0.63075184 |
| 173 | MP0001905_abnormal_dopamine_level | 0.59866902 |
| 174 | MP0001764_abnormal_homeostasis | 0.59579715 |
| 175 | MP0000313_abnormal_cell_death | 0.59170693 |
| 176 | MP0005621_abnormal_cell_physiology | 0.58780863 |
| 177 | MP0000609_abnormal_liver_physiology | 0.58161363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinemia (HP:0002154) | 6.19203551 |
| 2 | Gout (HP:0001997) | 5.66458679 |
| 3 | Hyperglycinuria (HP:0003108) | 5.44796889 |
| 4 | Carpal bone hypoplasia (HP:0001498) | 5.25824825 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 4.75551101 |
| 6 | Breast hypoplasia (HP:0003187) | 4.70148330 |
| 7 | Pancreatic cysts (HP:0001737) | 4.53473554 |
| 8 | Abnormality of alanine metabolism (HP:0010916) | 4.33665711 |
| 9 | Hyperalaninemia (HP:0003348) | 4.33665711 |
| 10 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.33665711 |
| 11 | Impulsivity (HP:0100710) | 4.30264956 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.30095225 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.30095225 |
| 14 | Adactyly (HP:0009776) | 4.10691580 |
| 15 | Small epiphyses (HP:0010585) | 4.06277973 |
| 16 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.05613225 |
| 17 | Flat capital femoral epiphysis (HP:0003370) | 4.00867286 |
| 18 | Irregular epiphyses (HP:0010582) | 3.99601605 |
| 19 | Absent hand (HP:0004050) | 3.97221443 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.58791887 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 3.58791887 |
| 22 | Pancreatic fibrosis (HP:0100732) | 3.57700439 |
| 23 | Capillary hemangiomas (HP:0005306) | 3.46763487 |
| 24 | True hermaphroditism (HP:0010459) | 3.45328728 |
| 25 | Rough bone trabeculation (HP:0100670) | 3.44044681 |
| 26 | Delayed epiphyseal ossification (HP:0002663) | 3.42762593 |
| 27 | Tetraplegia (HP:0002445) | 3.41244178 |
| 28 | Abnormality of the renal cortex (HP:0011035) | 3.40917268 |
| 29 | Increased purine levels (HP:0004368) | 3.40298403 |
| 30 | Hyperuricemia (HP:0002149) | 3.40298403 |
| 31 | Congenital stationary night blindness (HP:0007642) | 3.39950357 |
| 32 | Congenital, generalized hypertrichosis (HP:0004540) | 3.39681365 |
| 33 | Muscle fiber splitting (HP:0003555) | 3.36357924 |
| 34 | Entropion (HP:0000621) | 3.33952148 |
| 35 | Alopecia of scalp (HP:0002293) | 3.23766708 |
| 36 | Patellar aplasia (HP:0006443) | 3.23377488 |
| 37 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.19096017 |
| 38 | Decreased central vision (HP:0007663) | 3.17229098 |
| 39 | Oligomenorrhea (HP:0000876) | 3.13761213 |
| 40 | Duplicated collecting system (HP:0000081) | 3.10733850 |
| 41 | Nephronophthisis (HP:0000090) | 3.09696652 |
| 42 | Type II lissencephaly (HP:0007260) | 3.08815822 |
| 43 | Atrioventricular block (HP:0001678) | 2.96690468 |
| 44 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.94195149 |
| 45 | Cerebral hypomyelination (HP:0006808) | 2.93031618 |
| 46 | Hyperventilation (HP:0002883) | 2.88654784 |
| 47 | Abnormality of the renal collecting system (HP:0004742) | 2.88650743 |
| 48 | Facial hemangioma (HP:0000329) | 2.86953457 |
| 49 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.82954580 |
| 50 | Pustule (HP:0200039) | 2.80140044 |
| 51 | Pendular nystagmus (HP:0012043) | 2.79634192 |
| 52 | Renal cortical cysts (HP:0000803) | 2.78961841 |
| 53 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.77945493 |
| 54 | Abnormal trabecular bone morphology (HP:0100671) | 2.71249104 |
| 55 | Cystic liver disease (HP:0006706) | 2.70646086 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.68583608 |
| 57 | Attenuation of retinal blood vessels (HP:0007843) | 2.68430167 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.68001798 |
| 59 | Tubular atrophy (HP:0000092) | 2.67392192 |
| 60 | Absent epiphyses (HP:0010577) | 2.67019848 |
| 61 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.67019848 |
| 62 | Stenosis of the external auditory canal (HP:0000402) | 2.66621903 |
| 63 | Prostate neoplasm (HP:0100787) | 2.65221328 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 2.65015705 |
| 65 | Abnormality of the labia minora (HP:0012880) | 2.59709332 |
| 66 | Stillbirth (HP:0003826) | 2.59606587 |
| 67 | Progressive inability to walk (HP:0002505) | 2.58127190 |
| 68 | Glossoptosis (HP:0000162) | 2.56997049 |
| 69 | Abnormal spermatogenesis (HP:0008669) | 2.55656119 |
| 70 | Bundle branch block (HP:0011710) | 2.55365147 |
| 71 | Chronic hepatic failure (HP:0100626) | 2.55304491 |
| 72 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.53677165 |
| 73 | Abnormal biliary tract physiology (HP:0012439) | 2.52210304 |
| 74 | Bile duct proliferation (HP:0001408) | 2.52210304 |
| 75 | Shawl scrotum (HP:0000049) | 2.52175803 |
| 76 | Sparse eyelashes (HP:0000653) | 2.51841347 |
| 77 | Oligodactyly (hands) (HP:0001180) | 2.48520893 |
| 78 | Azoospermia (HP:0000027) | 2.47805305 |
| 79 | Pigmentary retinal degeneration (HP:0001146) | 2.45712204 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.45426084 |
| 81 | * Inability to walk (HP:0002540) | 2.45162861 |
| 82 | Increased corneal curvature (HP:0100692) | 2.43315321 |
| 83 | Keratoconus (HP:0000563) | 2.43315321 |
| 84 | Death in infancy (HP:0001522) | 2.42769041 |
| 85 | Sparse lateral eyebrow (HP:0005338) | 2.42189137 |
| 86 | Concave nail (HP:0001598) | 2.40780261 |
| 87 | Polydipsia (HP:0001959) | 2.39533840 |
| 88 | Abnormal drinking behavior (HP:0030082) | 2.39533840 |
| 89 | Clumsiness (HP:0002312) | 2.38431983 |
| 90 | Prominent supraorbital ridges (HP:0000336) | 2.37783523 |
| 91 | Epidermoid cyst (HP:0200040) | 2.35694916 |
| 92 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.34764121 |
| 93 | Male infertility (HP:0003251) | 2.34738800 |
| 94 | Large for gestational age (HP:0001520) | 2.34162553 |
| 95 | Progressive muscle weakness (HP:0003323) | 2.33399902 |
| 96 | Ventricular fibrillation (HP:0001663) | 2.32045614 |
| 97 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.31279348 |
| 98 | Enlarged penis (HP:0000040) | 2.30290384 |
| 99 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.30250619 |
| 100 | Congenital sensorineural hearing impairment (HP:0008527) | 2.28153173 |
| 101 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27275541 |
| 102 | Genu varum (HP:0002970) | 2.27127847 |
| 103 | Ileus (HP:0002595) | 2.26529465 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 2.24741361 |
| 105 | Metaphyseal cupping (HP:0003021) | 2.22774852 |
| 106 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.22399999 |
| 107 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22112947 |
| 108 | Restlessness (HP:0000711) | 2.19279758 |
| 109 | Hyperglycemia (HP:0003074) | 2.18884015 |
| 110 | Abnormality of purine metabolism (HP:0004352) | 2.18489010 |
| 111 | Ureteral duplication (HP:0000073) | 2.17318358 |
| 112 | Premature rupture of membranes (HP:0001788) | 2.17238690 |
| 113 | Ketosis (HP:0001946) | 2.17148578 |
| 114 | Areflexia of lower limbs (HP:0002522) | 2.17140668 |
| 115 | Abnormality of the hepatic vasculature (HP:0006707) | 2.15867417 |
| 116 | Glucose intolerance (HP:0000833) | 2.14374960 |
| 117 | Adrenal hypoplasia (HP:0000835) | 2.13825381 |
| 118 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.13596561 |
| 119 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.12063313 |
| 120 | Polyphagia (HP:0002591) | 2.11045504 |
| 121 | Breast aplasia (HP:0100783) | 2.10470945 |
| 122 | Gaze-evoked nystagmus (HP:0000640) | 2.10157244 |
| 123 | Absent radius (HP:0003974) | 2.09241549 |
| 124 | Thick nail (HP:0001805) | 2.09217921 |
| 125 | Decreased circulating renin level (HP:0003351) | 2.08265434 |
| 126 | CNS hypomyelination (HP:0003429) | 2.07709388 |
| 127 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07006588 |
| 128 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.06711384 |
| 129 | Secondary amenorrhea (HP:0000869) | 2.05983129 |
| 130 | Abnormality of femoral epiphyses (HP:0006499) | 2.04520263 |
| 131 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.04520263 |
| 132 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.04351322 |
| 133 | Furrowed tongue (HP:0000221) | 2.02729852 |
| 134 | Abnormality of the preputium (HP:0100587) | 2.01344634 |
| 135 | Abnormality of the femoral head (HP:0003368) | 2.00806382 |
| 136 | Short nail (HP:0001799) | 1.97323004 |
| 137 | Multiple enchondromatosis (HP:0005701) | 1.96118095 |
| 138 | Polyuria (HP:0000103) | 1.95775790 |
| 139 | Oligodactyly (HP:0012165) | 1.95766585 |
| 140 | Aplasia involving forearm bones (HP:0009822) | 1.95117795 |
| 141 | Absent forearm bone (HP:0003953) | 1.95117795 |
| 142 | Chromsome breakage (HP:0040012) | 1.94669309 |
| 143 | Sclerocornea (HP:0000647) | 1.94439041 |
| 144 | Genetic anticipation (HP:0003743) | 1.93792362 |
| 145 | Heart block (HP:0012722) | 1.93714056 |
| 146 | Cerebellar dysplasia (HP:0007033) | 1.93687779 |
| 147 | Congenital hepatic fibrosis (HP:0002612) | 1.92493852 |
| 148 | Submucous cleft hard palate (HP:0000176) | 1.91480849 |
| 149 | Progressive cerebellar ataxia (HP:0002073) | 1.90776546 |
| 150 | Hypophosphatemic rickets (HP:0004912) | 1.88803529 |
| 151 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.88760321 |
| 152 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87366997 |
| 153 | Osteolytic defects of the hand bones (HP:0009699) | 1.87366997 |
| 154 | Hypoglycemic coma (HP:0001325) | 1.86421012 |
| 155 | Generalized aminoaciduria (HP:0002909) | 1.86408845 |
| 156 | Stomach cancer (HP:0012126) | 1.86006178 |
| 157 | Delayed CNS myelination (HP:0002188) | 1.85734531 |
| 158 | Abnormal urine output (HP:0012590) | 1.85068891 |
| 159 | Pachygyria (HP:0001302) | 1.84426009 |
| 160 | Abnormality of chromosome stability (HP:0003220) | 1.83754614 |
| 161 | Metaphyseal irregularity (HP:0003025) | 1.83673489 |
| 162 | Nausea (HP:0002018) | 1.83150324 |
| 163 | Macular degeneration (HP:0000608) | 1.82812249 |
| 164 | Polycythemia (HP:0001901) | 1.82719260 |
| 165 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.82664147 |
| 166 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.82497725 |
| 167 | Absent/shortened dynein arms (HP:0200106) | 1.82497725 |
| 168 | Short middle phalanx of the 5th finger (HP:0004220) | 1.82403157 |
| 169 | Tachypnea (HP:0002789) | 1.82368499 |
| 170 | Ketoacidosis (HP:0001993) | 1.81903298 |
| 171 | Hypoplastic toenails (HP:0001800) | 1.81119032 |
| 172 | Hydroxyprolinuria (HP:0003080) | 1.80556496 |
| 173 | Abnormality of proline metabolism (HP:0010907) | 1.80556496 |
| 174 | Abnormal atrioventricular conduction (HP:0005150) | 1.80056052 |
| 175 | Meckel diverticulum (HP:0002245) | 1.78981715 |
| 176 | Prolonged partial thromboplastin time (HP:0003645) | 1.78742597 |
| 177 | Chorioretinal atrophy (HP:0000533) | 1.78710594 |
| 178 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.77908466 |
| 179 | Genital tract atresia (HP:0001827) | 1.75298786 |
| 180 | Gait imbalance (HP:0002141) | 1.75017976 |
| 181 | Male pseudohermaphroditism (HP:0000037) | 1.73716659 |
| 182 | Anencephaly (HP:0002323) | 1.73548249 |
| 183 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73417765 |
| 184 | Abnormal eating behavior (HP:0100738) | 1.73230805 |
| 185 | Congenital primary aphakia (HP:0007707) | 1.72899409 |
| 186 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.72791256 |
| 187 | Proximal tubulopathy (HP:0000114) | 1.72191786 |
| 188 | Vaginal atresia (HP:0000148) | 1.70862616 |
| 189 | Optic nerve hypoplasia (HP:0000609) | 1.70615404 |
| 190 | Postaxial foot polydactyly (HP:0001830) | 1.70321627 |
| 191 | Bulbous nose (HP:0000414) | 1.69437594 |
| 192 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.68881330 |
| 193 | Broad-based gait (HP:0002136) | 1.68785380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.14620168 |
| 2 | PDK2 | 4.16368510 |
| 3 | ADRBK2 | 4.11199699 |
| 4 | WEE1 | 3.16715290 |
| 5 | IRAK3 | 3.02100468 |
| 6 | AKT3 | 2.97230354 |
| 7 | GRK1 | 2.94915922 |
| 8 | PLK4 | 2.94418285 |
| 9 | TAOK3 | 2.93820656 |
| 10 | BMPR1B | 2.91388725 |
| 11 | BRSK2 | 2.77553262 |
| 12 | NEK2 | 2.74952119 |
| 13 | LATS2 | 2.70211205 |
| 14 | MKNK2 | 2.33926826 |
| 15 | MKNK1 | 2.26280991 |
| 16 | STK38L | 2.22983947 |
| 17 | BCKDK | 2.15137371 |
| 18 | INSRR | 2.12294849 |
| 19 | NEK6 | 2.04745408 |
| 20 | MAP4K2 | 2.03435057 |
| 21 | NUAK1 | 2.03327307 |
| 22 | EIF2AK1 | 2.02074542 |
| 23 | DAPK2 | 2.01892426 |
| 24 | PINK1 | 1.96371414 |
| 25 | CASK | 1.94720896 |
| 26 | TLK1 | 1.92353755 |
| 27 | BRSK1 | 1.83463935 |
| 28 | PLK3 | 1.78542110 |
| 29 | LATS1 | 1.78268745 |
| 30 | TTK | 1.77259397 |
| 31 | TXK | 1.75826399 |
| 32 | STK3 | 1.75043396 |
| 33 | DYRK3 | 1.71352855 |
| 34 | PLK1 | 1.67398489 |
| 35 | ADRBK1 | 1.57608716 |
| 36 | MAPK13 | 1.55972864 |
| 37 | ACVR1B | 1.52793085 |
| 38 | CAMKK2 | 1.47854663 |
| 39 | CCNB1 | 1.44147974 |
| 40 | WNK3 | 1.40905195 |
| 41 | EIF2AK3 | 1.40412496 |
| 42 | CAMK1 | 1.38152454 |
| 43 | CHEK2 | 1.32835839 |
| 44 | CDK8 | 1.31966630 |
| 45 | AURKB | 1.31436214 |
| 46 | CDK3 | 1.27825269 |
| 47 | MAPKAPK3 | 1.19498752 |
| 48 | VRK2 | 1.16990394 |
| 49 | TIE1 | 1.16407946 |
| 50 | CDC7 | 1.13330089 |
| 51 | TAOK1 | 1.12476139 |
| 52 | PRKCI | 1.11682764 |
| 53 | SRPK1 | 1.10493811 |
| 54 | TNIK | 1.10083576 |
| 55 | EPHB2 | 1.08837607 |
| 56 | NLK | 1.08269438 |
| 57 | TGFBR1 | 1.08197979 |
| 58 | KDR | 1.07991105 |
| 59 | MAP3K4 | 1.07704510 |
| 60 | PIK3CA | 1.07008722 |
| 61 | PRKAA1 | 1.06515559 |
| 62 | OXSR1 | 1.06083178 |
| 63 | BLK | 1.03191341 |
| 64 | CSNK1G3 | 0.99449442 |
| 65 | GRK5 | 0.95558836 |
| 66 | MUSK | 0.95412200 |
| 67 | ALK | 0.95238844 |
| 68 | PRKCE | 0.94477226 |
| 69 | MARK3 | 0.91836950 |
| 70 | CSNK1G1 | 0.90093353 |
| 71 | RPS6KA4 | 0.87713128 |
| 72 | NEK1 | 0.87566050 |
| 73 | CSNK1A1L | 0.86387222 |
| 74 | PAK6 | 0.84354718 |
| 75 | EPHA3 | 0.81452750 |
| 76 | PRKAA2 | 0.80970414 |
| 77 | PDK4 | 0.80852360 |
| 78 | PDK3 | 0.80852360 |
| 79 | ZAK | 0.79549636 |
| 80 | CDK7 | 0.77667791 |
| 81 | CSNK1G2 | 0.77385962 |
| 82 | CHEK1 | 0.76336256 |
| 83 | PKN1 | 0.75974437 |
| 84 | PRKCG | 0.75395094 |
| 85 | NME1 | 0.75184350 |
| 86 | MAP2K1 | 0.72270145 |
| 87 | NME2 | 0.69542556 |
| 88 | AURKA | 0.66930869 |
| 89 | MAP2K2 | 0.66661332 |
| 90 | PRKG2 | 0.65793143 |
| 91 | VRK1 | 0.64339630 |
| 92 | PHKG2 | 0.63968480 |
| 93 | PHKG1 | 0.63968480 |
| 94 | NTRK3 | 0.63798996 |
| 95 | EIF2AK2 | 0.62303754 |
| 96 | BRAF | 0.61422329 |
| 97 | TSSK6 | 0.60886550 |
| 98 | STK24 | 0.58704035 |
| 99 | IGF1R | 0.58212299 |
| 100 | MARK1 | 0.57041604 |
| 101 | MYLK | 0.56880169 |
| 102 | KSR2 | 0.55346870 |
| 103 | CAMK4 | 0.54746340 |
| 104 | CAMK1D | 0.54394012 |
| 105 | ABL2 | 0.54070744 |
| 106 | MAPK12 | 0.53949145 |
| 107 | EPHA4 | 0.53073095 |
| 108 | PRKCQ | 0.53030865 |
| 109 | SGK2 | 0.53010979 |
| 110 | PRKACA | 0.51721620 |
| 111 | MAPK7 | 0.51553622 |
| 112 | PRKG1 | 0.50473452 |
| 113 | IKBKB | 0.49768131 |
| 114 | CAMK2A | 0.49692372 |
| 115 | FER | 0.49026225 |
| 116 | MAPKAPK5 | 0.48572475 |
| 117 | STK38 | 0.47880453 |
| 118 | AKT2 | 0.47797294 |
| 119 | PRKACG | 0.47731109 |
| 120 | CDK2 | 0.47573052 |
| 121 | CDK4 | 0.47030847 |
| 122 | RIPK4 | 0.46691361 |
| 123 | NEK9 | 0.46499484 |
| 124 | MAP2K6 | 0.45867305 |
| 125 | PRKCZ | 0.45191432 |
| 126 | RPS6KA5 | 0.44935059 |
| 127 | TEC | 0.44691965 |
| 128 | MAP3K3 | 0.44501477 |
| 129 | MAPK11 | 0.44344726 |
| 130 | MELK | 0.43306584 |
| 131 | TRPM7 | 0.43172376 |
| 132 | KIT | 0.42546499 |
| 133 | CDK1 | 0.41709381 |
| 134 | RAF1 | 0.41412904 |
| 135 | PIM1 | 0.40631276 |
| 136 | FGR | 0.39200760 |
| 137 | MAP3K9 | 0.38787299 |
| 138 | MAP2K7 | 0.38068071 |
| 139 | PAK1 | 0.37474376 |
| 140 | YES1 | 0.37401200 |
| 141 | STK11 | 0.37398241 |
| 142 | ATM | 0.36297773 |
| 143 | SGK223 | 0.36131016 |
| 144 | SGK494 | 0.36131016 |
| 145 | DYRK2 | 0.35166946 |
| 146 | PDPK1 | 0.34463747 |
| 147 | ERBB2 | 0.33929272 |
| 148 | TRIM28 | 0.33220142 |
| 149 | ARAF | 0.32566991 |
| 150 | STK39 | 0.32440247 |
| 151 | PAK3 | 0.31940997 |
| 152 | MAPK15 | 0.31859965 |
| 153 | DDR2 | 0.31610700 |
| 154 | PDGFRB | 0.31427644 |
| 155 | PRKCA | 0.31223729 |
| 156 | MAPK10 | 0.31189510 |
| 157 | PIM2 | 0.31175453 |
| 158 | FRK | 0.31058600 |
| 159 | MAP3K7 | 0.30790611 |
| 160 | MAP3K8 | 0.30042157 |
| 161 | PTK2B | 0.30033211 |
| 162 | CSNK1A1 | 0.29140388 |
| 163 | MAP3K6 | 0.27964506 |
| 164 | WNK4 | 0.27043129 |
| 165 | MAPK9 | 0.26404576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 8.89773950 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 4.89245689 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.69421712 |
| 4 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.28115787 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.07806928 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.73088890 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66967684 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 2.54861346 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45387527 |
| 10 | Basal transcription factors_Homo sapiens_hsa03022 | 2.38562767 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.37363342 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.28713335 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.26543075 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23484812 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18894016 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12512723 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12071732 |
| 18 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 2.09935495 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08026315 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06943256 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04022133 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99577694 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.95206036 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.85417514 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78512786 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76088539 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75830221 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.70717378 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.66989613 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.61590399 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.59961681 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58357913 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 1.53255689 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.51909603 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.51271095 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.50731243 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48008209 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.44712621 |
| 39 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.43846175 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42302254 |
| 41 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.42293885 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.40804037 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38724553 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38132175 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36171864 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.35738155 |
| 47 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.32296175 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26949935 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26340524 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.25593102 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.25311675 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22557488 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22216974 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20660658 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10519859 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.10415646 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10030008 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.06090711 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02235955 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.99092427 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95572911 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93770587 |
| 63 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93131894 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88467628 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88351355 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87217349 |
| 67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86857816 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86480089 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82893402 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82051889 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 0.78186229 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77873133 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76962946 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.76883085 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71985101 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70861814 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.70234264 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69232061 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68397779 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67621231 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66099252 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64459463 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63636105 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63479396 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63320782 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60538101 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60440036 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60161212 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59391785 |
| 90 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59009115 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58375507 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57992856 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57665834 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55786954 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54806738 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54092637 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53166644 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49682309 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.49168233 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47612082 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47242718 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45847037 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44984461 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.43106189 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42980245 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42828152 |
| 107 | Proteasome_Homo sapiens_hsa03050 | 0.40139549 |
| 108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.38681661 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37653302 |
| 110 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35731731 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35375244 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35107948 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.35103961 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35073368 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34899289 |
| 116 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.34576258 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34345536 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33986768 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33005138 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32446940 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.31625569 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31164800 |
| 123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30810991 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27899782 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.27809710 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.27330343 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26593586 |
| 128 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25912334 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24634380 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23434412 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21472444 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.21422663 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20936981 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20600084 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20100604 |
| 136 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.19249021 |
| 137 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18459454 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17758569 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.17404192 |
| 140 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14973050 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14234079 |
| 142 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.13639416 |
| 143 | Prostate cancer_Homo sapiens_hsa05215 | 0.12723930 |
| 144 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.12006251 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.11733939 |
| 146 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.09360934 |
| 147 | Long-term depression_Homo sapiens_hsa04730 | 0.09358062 |
| 148 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08884444 |
| 149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06822216 |
| 150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05886550 |
| 151 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.05657192 |
| 152 | Mismatch repair_Homo sapiens_hsa03430 | 0.04876546 |
| 153 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.03525302 |
| 154 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03308245 |
| 155 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.02686810 |
| 156 | HTLV-I infection_Homo sapiens_hsa05166 | 0.01766975 |
| 157 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00663930 |

